📌 Key Takeaways
- Topic: HD Silica Explained: Highly Dispersible Silica Specs, Benefits and Tire Applications
- Keywords: bulk silica powder
- Published: 2026-11-20 02:15:55
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica as a Clarifying Agent: Uses in Beer, Wine and Beverages
- What Is Amorphous Silica? Types, Safety Profile and Industrial Uses
- Silica for Chromatography: Particle Size, Pore Size and Grade Selection
- Wagner, J. et al. Mesoporous silica nanoparticles as pH-responsive carrier for the immune-activating drug resiquimod enhance the local immune response in mice. ACS Nano 15, 4450-4466 (2021). Post CAS PubMed Google Scholar
- Silica Oil Absorption: What It Means, Typical Values and How It Affects Formulations
- Zhang, M. et al. Tumor environment responsive degradable CuS@mSiO 2 @MnO 2 /DOX for MRI guided synergistic chemo-photothermal therapy and chemodynamic therapy. Chem. Eng. J. 389, 124450 (2020). Piece CAS Google Scholar
- Quartz for Engineered Stone: Purity, Whiteness and Safety Requirements
- The unique properties of MSNs make it greatly superior for the construction of multifunctional nanocomposites and drug delivery system. Different therapeutic nanoplatforms obtained through the careful design of MSNs have revealed promising potential in the field of targeted disease therapy. Current applications of MSNs include tumor therapy, 367, 368, 369 anti-infection therapy (bacteria and virus), 370, 371, 372, 373 anti-oxidant/anti-inflammatory therapy (Alzheimer's disease, acute kidney injury, etc.), 374, 375, 376 and metabolic diseases treatment (diabetes, osteoporosis, fatty liver, etc) 377, 378, 379, 380 (Fig. 7 ). In general, the targeted therapeutic characteristics of MSNs can be reflected in the following aspects: (1) Loading chemotherapy drugs or other drugs with toxic side influences, so that they can be released in a controlled manner by MSNs at the targeted sites to prevent their premature release. (2) Selective enrichment at the lesion sites through passive targeting or active targeting, resulting in the higher therapeutic efficacy. (3) Use the MSNs matrix to develop a non-invasive, spatial and temporal controllable targeted therapeutic plan, consequently to overcome the limitations and defects of conventional clinical treatment modalities. To date, the emerging targeted therapeutic modalities developed based on MSNs include dynamic therapy such as photodynamic, sonodynamic and chemodynamic therapies, thermal ablation therapy such as photothermal therapy and magnetic thermotherapy, enzyme-like catalytic therapy, immunotherapy, gene therapy, and others. Meanwhile, the integration of various therapeutic modalities on a single MSNs is expected to enhance the therapeutic efficacy synergistically (Fig. 7 ). In this part, we will discuss MSNs-based therapeutic modalities.
How to Disperse Fumed Silica: Methods, Equipment and Common Mistakes
What is silica (SiO₂)?
silica carrier He, Q., Shi, J., Zhu, M., Chen, Y. & Chen, F. The three-stage in vitro degradation behavior of mesoporous silica in simulated body fluid. Micropor. Mesopor. Mater. 131, 314-320 (2010). Piece CAS Google Scholar
What is the difference between fumed silica and precipitated silica?
ultra pure silica Li, S. et al. Dual stimuli-responsive nanoplatform based on core-shell structured graphene oxide/mesoporous silica@ alginate. Int. J. Biol. Macromol. 175, 209-216 (2021). Post CAS PubMed Google Scholar
What drives silica raw material prices?
1250 mesh silica In this process, nanozymes are capable of following enzyme kinetics under physiological conditions and catalyzing the conversion of enzyme substrates by mimicking the structure or function of natural enzymes. Current nanozymes are dominated by oxidoreductase activity, i.e., oxidative stress amplification-related POD or OXD mimics, 423, 424 and antioxidation-related CAT or SOD mimics. 425, 426 By designing nanozymes with various catalytic activities, the redox balance of cells can be precisely regulated, i.e., enhanced ROS generation or ROS scavenging, enabling symptomatic treatment in a variety of disease models. 427, 428, 429, 430 Owing to the rich and tunable pore structure, MSNs have become a brilliant nanoreactor in enzyme-like catalytic therapy. 431, 432, 433, 434, 435 In a study by Wu et al., MSNs were developed as a compartmental hierarchical nanoreactor for multi-pathway generation of 1 O 2. Specifically, they designed a compartmental multienzyme nanoreactor with penetrated super cavity and connected dual mesoporous channels for the encapsulation of a multi-enzyme complex (SOD-lactoperoxidase (LPO)) and a photosensitizer ICG molecule. The cascade biocatalysis and enzyme-enhanced photosensitization could occur in parallel, due to the unimpeded substrate diffusion between SOD and LPO and reduced external diffusion effects. This strategy offers unique perks in the treatment of hypoxia tumors. 436 In terms of MSNs-based ROS elimination platform, Purikova et al. filled ultrasmall cerium dioxide (CeO 2 ) NPs with superior colloidal stability into the pore channels of MSNs, and functionalized the MSNs surface with ROS-responsive methylthiopropyl groups. The released CeO 2 NPs could scavenge more than 80% of H 2 O 2 within 10 min in an ROS-excess environment, which was demonstrated to be a potentially secure and productive antioxidant therapeutic agent. 437
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.